about
Gene Expression (mRNA) Markers for Differentiating between Malignant and Benign Follicular Thyroid TumoursMolecular differential diagnosis of follicular thyroid carcinoma and adenoma based on gene expression profiling by using formalin-fixed paraffin-embedded tissues.The Risk of Relapse in Papillary Thyroid Cancer (PTC) in the Context of BRAFV600E Mutation Status and Other Prognostic Factors.Impact of SNPs on methylation readouts by Illumina Infinium HumanMethylation450 BeadChip Array: implications for comparative population studies.BRAFV600E-Associated Gene Expression Profile: Early Changes in the Transcriptome, Based on a Transgenic Mouse Model of Papillary Thyroid Carcinoma.The frequency of polymorphic variants of filaggrin gene and clinical atopic dermatitisGene signature of the post-Chernobyl papillary thyroid cancerDifferences in the transcriptome of medullary thyroid cancer regarding the status and type of RET gene mutations.Gene expression profile of human thyroid cancer in relation to its mutational status.Mouse models of papillary thyroid carcinoma - short review.Brain Metastasis Prediction by Transcriptomic Profiling in Triple-Negative Breast Cancer.The prevalence of somatic RAS mutations in medullary thyroid cancer - a Polish population study.Guidelines of Polish National Societies Diagnostics and Treatment of Thyroid Carcinoma. 2018 Update.Age at diagnosis and gender modify the risk of 9q22 and 14q13 polymorphisms for papillary thyroid carcinoma.Somatic mutation profiling of follicular thyroid cancer by next generation sequencing.Coexistence of Promoter Mutations and the V600E Alteration and Its Impact on Histopathological Features of Papillary Thyroid Carcinoma in a Selected Series of Polish PatientsUnsupervised analysis of follicular thyroid tumours transcriptome by oligonucleotide microarray gene expression profiling
P50
Q30313129-20E5BB4F-C783-49D9-9BAA-B906B298E249Q31141133-794A1C00-77EB-495C-B778-1EE176AC7785Q35692478-0605B39F-2868-4377-AB48-7C9D8FFF4ED1Q35852853-41D96AB5-2055-4A8D-BCA0-CA7F52AF0861Q35857363-D04A7B5B-1033-4CFE-B2B1-F38744A9A60AQ36690488-E0D02646-D308-4F25-B48A-72180FF6D08FQ36908328-FDAF1C00-7BF1-4007-B8DE-6E0C219DC50AQ37633558-95076794-2014-4DB3-84FC-83CEEBA52BB1Q37907665-84165CD0-DA9B-413A-B1D0-906CE975AA2BQ38809066-286D5C2D-21FC-4845-BD38-9E2D3506C0A3Q38815778-66816AAF-4A42-4CF5-952F-B50416A3368BQ40990419-E45CCF27-40DD-4434-B0A3-3C0FB01704CCQ50016120-08A3FE45-BB77-4AF1-B342-5603B1AABDBCQ50917237-EB0AF9CC-9703-4605-A0CC-B43566519315Q51710746-84B5A75F-696A-4706-83ED-61CC5CE5B2E5Q57210092-27BBD621-2859-4CCD-B2D1-8F1D8FCE1FF2Q86639257-D0D9A183-2C97-4FAA-B806-70F35142EA7D
P50
description
onderzoeker
@nl
researcher ORCID ID = 0000-0003-4115-3751
@en
name
Dagmara Rusinek
@ast
Dagmara Rusinek
@en
Dagmara Rusinek
@es
Dagmara Rusinek
@nl
type
label
Dagmara Rusinek
@ast
Dagmara Rusinek
@en
Dagmara Rusinek
@es
Dagmara Rusinek
@nl
prefLabel
Dagmara Rusinek
@ast
Dagmara Rusinek
@en
Dagmara Rusinek
@es
Dagmara Rusinek
@nl
P106
P1153
23498939500
P31
P496
0000-0003-4115-3751